Search results
GSK and Ochre Bio link to explore liver disease drivers
Pharmaceutical Technology via Yahoo Finance· 3 days agoGSK AI and machine learning global head and senior vice-president Kim Branson stated: “In addition...
Hologic, Inc. (NASDAQ:HOLX) Shares Sold by Northern Trust Corp
ETF DAILY NEWS· 7 days agoNorthern Trust Corp reduced its holdings in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 6.9% in the 4th quarter, HoldingsChannel.com reports. The firm owned 2,708,357 shares of the medical ...
Barinthus Biotherapeutics to slash about 25% of its workforce
Market Watch· 4 days agoexpects to cut about 25% of its workforce in connection with a pipeline prioritization. The company said it will prioritize development of VTP-300 in chronic hepatitis < ...
State ordered 201 Long Island schools to bar students because of bogus vaccination records
Newsday· 2 days agoThe state Health Department in January ordered 201 schools across Long Island to bar students from...
Gilead Sciences Inc's Dividend Analysis
GuruFocus.com via Yahoo Finance· 2 days agoGilead Sciences Inc (NASDAQ:GILD) recently announced a dividend of $0.77 per share, payable on 2024-06-27, with the ex-dividend date set for 2024-06-14....
Adam S. Grossman Sells 100,000 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) Stock
ETF DAILY NEWS· 17 hours agoADMA Biologics, Inc. (NASDAQ:ADMA – Get Free Report) CEO Adam S. Grossman sold 100,000 shares of the business’s stock in a transaction dated Friday, June 14th. The shares were sold at an average ...
Oregon to receive $15 million in settlement over baby powder lawsuit
NewsWatch 12 Medford - Klamath Falls· 5 days agoOregon will receive $15 million from Johnson & Johnson to settle allegations that the pharmaceutical...
Orally Administered NV-387 Results in Ideal Flat Blood Concentration Profile for Sustained Antiviral...
The News & Observer· 5 days agoA First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More
Barinthus Biotherapeutics (NASDAQ:BRNS) Stock Rating Reaffirmed by William Blair
ETF DAILY NEWS· 2 days agoBarinthus Biotherapeutics (NASDAQ:BRNS – Get Free Report)‘s stock had its “outperform” rating reaffirmed by equities researchers at William Blair in a report issued on Thursday, RTT News reports ...
What vaccine protects against cancer and is recommended for everyone?
Galveston County Daily News· 4 days agoIn honor of all the students taking finals this time of the year, here is a little Vaccine Smarts...